jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

May. 22, 2024

Nov. 11, 2025

jRCT1031240102

A safety epidemiological study assessing the effect of Daikenchuto (TJ-100) on the risk of liver injury in cancer patients who underwent colectomy or gastrectomy

A safety epidemiological study assessing the effect of Daikenchuto (TJ-100) on the risk of liver injury in cancer patients who underwent colectomy or gastrectomy

asakawa takeshi

TSUMURA & CO.

3586 Yoshiwara, Ami-machi, Inashiki-gun, Ibaraki

+81-29-889-3862

tsu_jp_rd_ds01@mail.tsumura.co.jp

wada yuu

TSUMURA & CO.

3586 Yoshiwara, Ami-machi, Inashiki-gun, Ibaraki

+81-29-889-3862

tsu_jp_rd_ds01@mail.tsumura.co.jp

Not Recruiting

May. 22, 2024

Observational

other

Colon cancer patients who underwent colon surgery and gastric cancer patients who underwent gastrectomy between April 2008 and May 2019

Patients who meet the following criteria will be excluded.
Cancer patients who underwent complex surgery
Patients who underwent hepatectomy
Patients diagnosed with liver comorbidities before surgery
Patients who were prescribed choleretic agents or hepatoprotective drugs before surgery
Patients prescribed antibiotics before surgery
Patients prescribed anti-tumor drugs before surgery
Patients who received blood transfusion on the day before surgery

No limit
No limit

stomach cancer

Whether there is a record of being prescribed choleretic agents or liver-protecting drugs

Whether there is a record of being prescribed a choleretic agent or a liver-protecting drug and a steroid preparation.

TSUMURA & CO.
Shiba Palace Clinic Ethics Review Committee
1-9-10 Hamamatsucho, Minato-ku, Tokyo, Tokyo
Approval

None

History of Changes

No Publication date
2 Nov. 11, 2025 (this page) Changes
1 May. 22, 2024 Detail